![5-Chloro-N-[[[4-[6-fluoro-1,4-dihydro-7-(methylamino)-2,4-dioxo-3(2H)-quinazolinyl]phenyl]amino]ca…](https://static.cymitquimica.com/products/3D/img/FC103583.png "Cliccare per ingrandire")
5-Chloro-N-[[[4-[6-fluoro-1,4-dihydro-7-(methylamino)-2,4-dioxo-3(2H)-quinazolinyl]phenyl]amino]carbonyl]-2-thiophenesulfonamide
CAS: 936500-94-6
Rif. 3D-FC103583
| 100mg | Prezzo su richiesta |
Informazioni sul prodotto
- N-[4-(6-Fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)phenyl]-N′-[(5-chlorothiophen-2-yl)sulfonyl]urea
- 2-Thiophenesulfonamide, 5-chloro-N-[[[4-[6-fluoro-1,4-dihydro-7-(methylamino)-2,4-dioxo-3(2H)-quinazolinyl]phenyl]amino]carbonyl]-
- PRT 060128
- Elinogrel
Prasugrel is a thrombin receptor antagonist that inhibits the binding of thrombin to its receptor, which prevents the conversion of fibrinogen to fibrin. It has been shown to be an effective treatment for myocardial infarction (MI). Prasugrel is a prodrug and metabolized by hydrolysis in plasma and liver. The pharmacokinetic properties of prasugrel are determined by hepatic cytochrome P450 activity, influenced by genetic polymorphisms, and may be modified by drugs such as heparin. Prasugrel also inhibits platelet aggregation and adhesion through cation channel inhibition.
Proprietà chimiche
Richiesta tecnica su: 3D-FC103583 5-Chloro-N-[[[4-[6-fluoro-1,4-dihydro-7-(methylamino)-2,4-dioxo-3(2H)-quinazolinyl]phenyl]amino]carbonyl]-2-thiophenesulfonamide
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
